Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-24-006213

Head of Pharm Ops and Tech gave up 610 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 1,260 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Murphy Nicole · Head of Pharm Ops and Tech

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-16 Exercise or conversion : show line 1 in the form +856 9,623.99 D
2024-02-16 Shares withheld for taxes : show line 2 in the form −414 $219.08 $90,699 9,209.99 D
2024-02-16 Exercise or conversion : show line 3 in the form +404 9,613.99 D
2024-02-16 Shares withheld for taxes : show line 4 in the form −196 $219.08 $42,940 9,417.99 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-02-16 Exercise or conversion : show line 5 in the form Performance Stock Unit −856 0 D
2024-02-16 Exercise or conversion : show line 6 in the form Restricted Stock Unit −404 504 D
2024-02-16 Other disposition : show line 7 in the form Restricted Stock Unit −504 0 D
Loading xslF345X05/form4.xml…